BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37748583)

  • 1. A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3.
    Feng Q; Chen J; Huang J; Li X; Liu X; Xiao C; Zheng X; Chen X; Li J; Gu Z; Luo K; Xiao K; Li W
    J Control Release; 2023 Nov; 363():349-360. PubMed ID: 37748583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC.
    MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
    Cancer Lett; 2018 Aug; 428():117-126. PubMed ID: 29653268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
    Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
    J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers.
    Chang YF; Lim KH; Chiang YW; Sie ZL; Chang J; Ho AS; Cheng CC
    BMC Cancer; 2019 Oct; 19(1):959. PubMed ID: 31619200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and activity of BBI608 derivatives targeting on stem cells.
    Zhou Q; Peng C; Du F; Zhou L; Shi Y; Du Y; Liu D; Sun W; Zhang M; Chen G
    Eur J Med Chem; 2018 May; 151():39-50. PubMed ID: 29604543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.
    Wang Q; Lu B; Zhang Y; Yu J; Guo J; Zhou Q; Lv H; Sun Y
    Hum Cell; 2021 Nov; 34(6):1855-1865. PubMed ID: 34370268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 10. STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration.
    Chen J; Huang S; Li H; Li Y; Zeng H; Hu J; Lin Y; Cai H; Deng P; Song T; Guan T; Zeng H; Liu M
    Clin Transl Oncol; 2023 Mar; 25(3):662-672. PubMed ID: 36422798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
    Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B
    Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.
    Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T
    Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer.
    Huang J; Zhuang C; Chen J; Chen X; Li X; Zhang T; Wang B; Feng Q; Zheng X; Gong M; Gong Q; Xiao K; Luo K; Li W
    Adv Mater; 2022 Jul; 34(27):e2201516. PubMed ID: 35481881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.
    Zheng Q; Dong H; Mo J; Zhang Y; Huang J; Ouyang S; Shi S; Zhu K; Qu X; Hu W; Liu P; Wang Y; Zhang X
    Theranostics; 2021; 11(2):824-840. PubMed ID: 33391507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ovarian cancer by low-intensity ultrasound through depletion of IL-6/STAT3 inflammatory pathway-maintained cancer stemness.
    Gong T; Zhang P; Jia L; Pan Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):820-826. PubMed ID: 32273089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.
    Malanga D; De Marco C; Guerriero I; Colelli F; Rinaldo N; Scrima M; Mirante T; De Vitis C; Zoppoli P; Ceccarelli M; Riccardi M; Ravo M; Weisz A; Federico A; Franco R; Rocco G; Mancini R; Rizzuto A; Gulletta E; Ciliberto G; Viglietto G
    Oncotarget; 2015 Dec; 6(40):42667-86. PubMed ID: 26486080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
    Liu S; Ge X; Su L; Zhang A; Mou X
    Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.